1. Home
  2. NVMI vs EXEL Comparison

NVMI vs EXEL Comparison

Compare NVMI & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nova Ltd.

NVMI

Nova Ltd.

HOLD

Current Price

$450.16

Market Cap

15.1B

Sector

Technology

ML Signal

HOLD

Logo Exelixis Inc.

EXEL

Exelixis Inc.

HOLD

Current Price

$55.57

Market Cap

14.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVMI
EXEL
Founded
1993
1994
Country
Israel
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.1B
14.0B
IPO Year
2001
2000

Fundamental Metrics

Financial Performance
Metric
NVMI
EXEL
Price
$450.16
$55.57
Analyst Decision
Strong Buy
Buy
Analyst Count
8
21
Target Price
$431.88
$46.50
AVG Volume (30 Days)
490.2K
2.5M
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.95
EPS
N/A
0.79
Revenue
N/A
$452,477,000.00
Revenue This Year
$20.94
$13.61
Revenue Next Year
$19.53
$13.13
P/E Ratio
$56.79
$69.59
Revenue Growth
N/A
N/A
52 Week Low
$232.73
$33.76
52 Week High
$615.99
$57.57

Technical Indicators

Market Signals
Indicator
NVMI
EXEL
Relative Strength Index (RSI) 43.09 48.96
Support Level $415.57 $40.53
Resistance Level $487.97 $57.57
Average True Range (ATR) 20.54 1.32
MACD -1.26 -0.33
Stochastic Oscillator 42.54 2.45

Price Performance

Historical Comparison
NVMI
EXEL

About NVMI Nova Ltd.

Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing. The company provides high-performance metrology solutions across the semiconductor fabrication lifecycle and develops differentiated inline metrology solutions deployed by a broad range of customers, including integrated circuit manufacturers. Its portfolio combines high-precision hardware and software, enabling customers to improve device performance, enhance yields, and accelerate time to market. Its products include Dimensional Metrology, Materials Metrology, Chemical Metrology, and Software Solutions. The company operates in China, Taiwan, R.O.C., the United States and other regions, with maximum revenue coming from China.

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Share on Social Networks: